img

Global Opioids Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Opioids Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Opioids Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Opioids Drug market is projected to reach US$ 8836.3 million in 2034, increasing from US$ 10050 million in 2022, with the CAGR of -1.8% during the period of 2024 to 2034. Demand from Pain Relief and Anesthesia are the major drivers for the industry.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Opioids Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl

Segment by Application


Pain Relief
Anesthesia
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Opioids Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Opioids Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Opioids Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Opioids Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Opioids Drug introduction, etc. Opioids Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Opioids Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Opioids Drug Market Overview
1.1 Opioids Drug Product Overview
1.2 Opioids Drug Market Segment by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.3 Global Opioids Drug Market Size by Type
1.3.1 Global Opioids Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Opioids Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Opioids Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioids Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Opioids Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Opioids Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Opioids Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Opioids Drug Sales Breakdown by Type (2018-2024)
2 Global Opioids Drug Market Competition by Company
2.1 Global Top Players by Opioids Drug Sales (2018-2024)
2.2 Global Top Players by Opioids Drug Revenue (2018-2024)
2.3 Global Top Players by Opioids Drug Price (2018-2024)
2.4 Global Top Manufacturers Opioids Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioids Drug Market Competitive Situation and Trends
2.5.1 Opioids Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioids Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Opioids Drug Market
2.8 Key Manufacturers Opioids Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioids Drug Status and Outlook by Region
3.1 Global Opioids Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Opioids Drug Historic Market Size by Region
3.2.1 Global Opioids Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Opioids Drug Sales in Value by Region (2018-2024)
3.2.3 Global Opioids Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Opioids Drug Forecasted Market Size by Region
3.3.1 Global Opioids Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Opioids Drug Sales in Value by Region (2024-2034)
3.3.3 Global Opioids Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Opioids Drug by Application
4.1 Opioids Drug Market Segment by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Others
4.2 Global Opioids Drug Market Size by Application
4.2.1 Global Opioids Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Opioids Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Opioids Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioids Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Opioids Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Opioids Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Opioids Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Opioids Drug Sales Breakdown by Application (2018-2024)
5 North America Opioids Drug by Country
5.1 North America Opioids Drug Historic Market Size by Country
5.1.1 North America Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Opioids Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Opioids Drug Sales in Value by Country (2018-2024)
5.2 North America Opioids Drug Forecasted Market Size by Country
5.2.1 North America Opioids Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Opioids Drug Sales in Value by Country (2024-2034)
6 Europe Opioids Drug by Country
6.1 Europe Opioids Drug Historic Market Size by Country
6.1.1 Europe Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Opioids Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Opioids Drug Sales in Value by Country (2018-2024)
6.2 Europe Opioids Drug Forecasted Market Size by Country
6.2.1 Europe Opioids Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Opioids Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Opioids Drug by Region
7.1 Asia-Pacific Opioids Drug Historic Market Size by Region
7.1.1 Asia-Pacific Opioids Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Opioids Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Opioids Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Opioids Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioids Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Opioids Drug Sales in Value by Region (2024-2034)
8 Latin America Opioids Drug by Country
8.1 Latin America Opioids Drug Historic Market Size by Country
8.1.1 Latin America Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Opioids Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Opioids Drug Sales in Value by Country (2018-2024)
8.2 Latin America Opioids Drug Forecasted Market Size by Country
8.2.1 Latin America Opioids Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Opioids Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Opioids Drug by Country
9.1 Middle East and Africa Opioids Drug Historic Market Size by Country
9.1.1 Middle East and Africa Opioids Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Opioids Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Opioids Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Opioids Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioids Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Opioids Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Teva Opioids Drug Products Offered
10.1.5 Teva Recent Development
10.2 Purdue Pharma
10.2.1 Purdue Pharma Company Information
10.2.2 Purdue Pharma Introduction and Business Overview
10.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Purdue Pharma Opioids Drug Products Offered
10.2.5 Purdue Pharma Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mallinckrodt Opioids Drug Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Amneal Pharma
10.4.1 Amneal Pharma Company Information
10.4.2 Amneal Pharma Introduction and Business Overview
10.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amneal Pharma Opioids Drug Products Offered
10.4.5 Amneal Pharma Recent Development
10.5 Collegium
10.5.1 Collegium Company Information
10.5.2 Collegium Introduction and Business Overview
10.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Collegium Opioids Drug Products Offered
10.5.5 Collegium Recent Development
10.6 J&J
10.6.1 J&J Company Information
10.6.2 J&J Introduction and Business Overview
10.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 J&J Opioids Drug Products Offered
10.6.5 J&J Recent Development
10.7 Endo
10.7.1 Endo Company Information
10.7.2 Endo Introduction and Business Overview
10.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Endo Opioids Drug Products Offered
10.7.5 Endo Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Pfizer Opioids Drug Products Offered
10.8.5 Pfizer Recent Development
10.9 INSYS
10.9.1 INSYS Company Information
10.9.2 INSYS Introduction and Business Overview
10.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 INSYS Opioids Drug Products Offered
10.9.5 INSYS Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mylan Opioids Drug Products Offered
10.10.5 Mylan Recent Development
10.11 Hikma
10.11.1 Hikma Company Information
10.11.2 Hikma Introduction and Business Overview
10.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hikma Opioids Drug Products Offered
10.11.5 Hikma Recent Development
10.12 Egalet
10.12.1 Egalet Company Information
10.12.2 Egalet Introduction and Business Overview
10.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Egalet Opioids Drug Products Offered
10.12.5 Egalet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioids Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioids Drug Industrial Chain Analysis
11.4 Opioids Drug Market Dynamics
11.4.1 Opioids Drug Industry Trends
11.4.2 Opioids Drug Market Drivers
11.4.3 Opioids Drug Market Challenges
11.4.4 Opioids Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioids Drug Distributors
12.3 Opioids Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oxycodone
Table 2. Major Company of Hydromorphone
Table 3. Major Company of Codeine
Table 4. Major Company of Fentanyl
Table 5. Global Opioids Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Opioids Drug Sales by Type (2018-2024) & (M Units)
Table 7. Global Opioids Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Opioids Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Opioids Drug Market Share in Value by Type (2018-2024)
Table 10. Global Opioids Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Opioids Drug Sales by Type (2024-2034) & (M Units)
Table 12. Global Opioids Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Opioids Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Opioids Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Opioids Drug Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Opioids Drug Sales by Type (2018-2024) & (M Units)
Table 17. North America Opioids Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Opioids Drug Sales (M Units) by Type (2018-2024)
Table 19. Europe Opioids Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Opioids Drug Sales (M Units) by Type (2018-2024)
Table 21. Asia-Pacific Opioids Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Opioids Drug Sales (M Units) by Type (2018-2024)
Table 23. Latin America Opioids Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Opioids Drug Sales (M Units) by Type (2018-2024)
Table 25. Middle East and Africa Opioids Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Opioids Drug Sales by Company (2018-2024) & (M Units)
Table 27. Global Opioids Drug Sales Share by Company (2018-2024)
Table 28. Global Opioids Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Opioids Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Opioids Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Opioids Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Opioids Drug Market
Table 35. Key Manufacturers Opioids Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Opioids Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Opioids Drug Sales by Region (2018-2024) & (M Units)
Table 39. Global Opioids Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Opioids Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Opioids Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Opioids Drug Sales by Region (2024-2034) & (M Units)
Table 44. Global Opioids Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Opioids Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Opioids Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Opioids Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Opioids Drug Sales by Application (2018-2024) & (M Units)
Table 50. Global Opioids Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Opioids Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Opioids Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Opioids Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Opioids Drug Sales by Application (2024-2034) & (M Units)
Table 55. Global Opioids Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Opioids Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Opioids Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Opioids Drug Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Opioids Drug Sales by Application (2018-2024) (M Units)
Table 60. North America Opioids Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Opioids Drug Sales by Application (2018-2024) (M Units)
Table 62. Europe Opioids Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Opioids Drug Sales by Application (2018-2024) (M Units)
Table 64. Asia-Pacific Opioids Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Opioids Drug Sales by Application (2018-2024) (M Units)
Table 66. Latin America Opioids Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Opioids Drug Sales by Application (2018-2024) (M Units)
Table 68. Middle East and Africa Opioids Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Opioids Drug Sales by Country (2018-2024) & (M Units)
Table 70. North America Opioids Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Opioids Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Opioids Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Opioids Drug Sales by Country (2024-2034) & (M Units)
Table 74. North America Opioids Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Opioids Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Opioids Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Opioids Drug Sales by Country (2018-2024) & (M Units)
Table 78. Europe Opioids Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Opioids Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Opioids Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Opioids Drug Sales by Country (2024-2034) & (M Units)
Table 82. Europe Opioids Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Opioids Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Opioids Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Opioids Drug Sales by Region (2018-2024) & (M Units)
Table 86. Asia-Pacific Opioids Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Opioids Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Opioids Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Opioids Drug Sales by Region (2024-2034) & (M Units)
Table 90. Asia-Pacific Opioids Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Opioids Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Opioids Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Opioids Drug Sales by Country (2018-2024) & (M Units)
Table 94. Latin America Opioids Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Opioids Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Opioids Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Opioids Drug Sales by Country (2024-2034) & (M Units)
Table 98. Latin America Opioids Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Opioids Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Opioids Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Opioids Drug Sales by Country (2018-2024) & (M Units)
Table 102. Middle East and Africa Opioids Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Opioids Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Opioids Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Opioids Drug Sales by Country (2024-2034) & (M Units)
Table 106. Middle East and Africa Opioids Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Opioids Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Opioids Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Teva Company Information
Table 110. Teva Introduction and Business Overview
Table 111. Teva Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Teva Opioids Drug Product
Table 113. Teva Recent Development
Table 114. Purdue Pharma Company Information
Table 115. Purdue Pharma Introduction and Business Overview
Table 116. Purdue Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Purdue Pharma Opioids Drug Product
Table 118. Purdue Pharma Recent Development
Table 119. Mallinckrodt Company Information
Table 120. Mallinckrodt Introduction and Business Overview
Table 121. Mallinckrodt Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Mallinckrodt Opioids Drug Product
Table 123. Mallinckrodt Recent Development
Table 124. Amneal Pharma Company Information
Table 125. Amneal Pharma Introduction and Business Overview
Table 126. Amneal Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Amneal Pharma Opioids Drug Product
Table 128. Amneal Pharma Recent Development
Table 129. Collegium Company Information
Table 130. Collegium Introduction and Business Overview
Table 131. Collegium Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Collegium Opioids Drug Product
Table 133. Collegium Recent Development
Table 134. J&J Company Information
Table 135. J&J Introduction and Business Overview
Table 136. J&J Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. J&J Opioids Drug Product
Table 138. J&J Recent Development
Table 139. Endo Company Information
Table 140. Endo Introduction and Business Overview
Table 141. Endo Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Endo Opioids Drug Product
Table 143. Endo Recent Development
Table 144. Pfizer Company Information
Table 145. Pfizer Introduction and Business Overview
Table 146. Pfizer Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Pfizer Opioids Drug Product
Table 148. Pfizer Recent Development
Table 149. INSYS Company Information
Table 150. INSYS Introduction and Business Overview
Table 151. INSYS Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. INSYS Opioids Drug Product
Table 153. INSYS Recent Development
Table 154. Mylan Company Information
Table 155. Mylan Introduction and Business Overview
Table 156. Mylan Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Mylan Opioids Drug Product
Table 158. Mylan Recent Development
Table 159. Hikma Company Information
Table 160. Hikma Introduction and Business Overview
Table 161. Hikma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Hikma Opioids Drug Product
Table 163. Hikma Recent Development
Table 164. Egalet Company Information
Table 165. Egalet Introduction and Business Overview
Table 166. Egalet Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Egalet Opioids Drug Product
Table 168. Egalet Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Opioids Drug Market Trends
Table 172. Opioids Drug Market Drivers
Table 173. Opioids Drug Market Challenges
Table 174. Opioids Drug Market Restraints
Table 175. Opioids Drug Distributors List
Table 176. Opioids Drug Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Opioids Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Opioids Drug Sales Status and Outlook (2018-2034) & (M Units)
Figure 5. Product Picture of Oxycodone
Figure 6. Global Oxycodone Sales YoY Growth (2018-2034) & (M Units)
Figure 7. Product Picture of Hydromorphone
Figure 8. Global Hydromorphone Sales YoY Growth (2018-2034) & (M Units)
Figure 9. Product Picture of Codeine
Figure 10. Global Codeine Sales YoY Growth (2018-2034) & (M Units)
Figure 11. Product Picture of Fentanyl
Figure 12. Global Fentanyl Sales YoY Growth (2018-2034) & (M Units)
Figure 13. Global Opioids Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Opioids Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Opioids Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Opioids Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Opioids Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Opioids Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Opioids Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Opioids Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Opioids Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Opioids Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Opioids Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Opioids Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Drug Revenue in 2022
Figure 27. Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Pain Relief
Figure 29. Global Pain Relief Sales YoY Growth (2018-2034) & (M Units)
Figure 30. Product Picture of Anesthesia
Figure 31. Global Anesthesia Sales YoY Growth (2018-2034) & (M Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (M Units)
Figure 34. Global Opioids Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Opioids Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Opioids Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Opioids Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Opioids Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Opioids Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Opioids Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Opioids Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Opioids Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Opioids Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Opioids Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Opioids Drug Manufacturing Cost Structure
Figure 47. Opioids Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries